"Satellite Healthcare West San Leandro is a dialysis clinic dedicated to improving the lives of patients with Chronic Kidney Disease in West San Leandro, California."

During the past decade, Satellite Dialysis West San Leandro conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Satellite Dialysis West San Leandro" are "ESRD" (1 trials), "Fatigue" (1 trials), "Hemodialysis-Induced Symptom" (1 trials), "Kidney Failure, Chronic" (1 trials) and "Renal Dialysis" (1 trials). Many other conditions were trialed in "Satellite Dialysis West San Leandro" in a lesser frequency.

Most popular intervention types in "Satellite Dialysis West San Leandro" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Blood Flow Rate Reduction" (1 trials), "Control" (1 trials) and "No intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Satellite Dialysis West San Leandro" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Satellite Dialysis West San Leandro". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Satellite Dialysis West San Leandro, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Satellite Dialysis West San Leandro, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".